Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 51, Issue 1, 2010, Pages 61-65

  Al Khabori, Murtadha ^a   Minden, Mark D ^a   Yee, Karen W L ^a   Gupta, Vikas ^a   Schimmer, Aaron D ^a   Schuh, Andre C ^a   Xu, Wei ^a   Brandwein, Joseph M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute lymphoblastic leukemia; Chemotherapeutic approaches; Prognostication

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CEREBROSPINAL FLUID ANALYSIS; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; T CELL LEUKEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PEDIATRICS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 74949134816     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428190903388376     Document Type: Article

References (14)

1. Boucheix C, David B, Sebban C, et al. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood 1994;84:1603-1612.
2. Uckun FM, Reaman G, Steinherez PG, et al. Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study. Leuk Lymphoma 1996;24: 57-70.
3. Huguet F, Leguay T, Raffoux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRAALL-2003 study. J Clin Oncol 2009;27:911-918.
4. Storring JM, Minden MD, Kao S, et al. Treatment of adults with BCR-ABL1 negative acute lymphoblastic leukemia with a modified pediatric regimen. Br J Haematol 2009;146: 76-85.
5. Al Khabori M, Samiee S, Fung S, et al. Adult precursor T-lymphoblastic leukemia/lymphoma with myeloid-associated antigen expression is associated with a lower complete remission rate following induction chemotherapy. Acta Haematol 2008;120:5-10.
6. Stewart K, Keating A, Sutton D, et al. Adult acute lymphoblastic leukaemia: the value of therapy intensification. Leuk Lymphoma 1991;4:103-110.
7. Kantarjian H, Thomas D, O'Brien S, et al. Long-term followup results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a doseintensive regimen, in adult acute lymphocytic leukemia. Cancer 2004;101:2788-2801.
8. Rowe JM, Buck G, Burnett AK, et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005;106:3760-3767.
9. Gupta V, Yi Q-L, Brandwein J, et al. The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs. no donor comparison. Bone Marrow Transplant 2004;33:397-404.
10. Barry E, DeAngelo DJ, Neuberg D, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol 2007;25:813-819. (Pubitemid 350002881)
11. Greenwood MJ, Seftel MD, Richardson C, et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma 2006;47: 1245-1252.
12. Burger B, Zimmermann M, Mann G, et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol 2003; 21:184-188.
13. Lazarus HM, Richards SM, Chopra R, et al. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood 2006;108:465-472.
14. Boissel N, Auclerc M-F, Lheritier V, et al. Should Adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 Trials. J Clin Oncol 2003;21:774-780.